Rising Prevalence Of Hypertension Is Fuelling The Growth Of The Market Due To Increasing Incidence And Health Risks Associated With High Blood Pressure Is Supporting Development Across The Sartans Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Expansion Is Expected For The Sartans Market Over The Forecast Period?

The sartans market size has shown consistent expansion in recent years. It is anticipated to increase from $22.18 billion in 2025 to $23.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.1%. This historical growth can be linked to factors such as the high global incidence of hypertension, the significant burden of cardiovascular diseases, the widespread uptake of generic drugs, the prevalence of hospital-based prescribing, and the proven long-term safety profile of sartans.

The sartans market is projected to experience consistent expansion over the upcoming years. It is anticipated to reach $27.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.1%. This growth during the forecast period can be attributed to factors such as an aging demographic, the increasing incidence of kidney disease, the demand for cost-effective therapies, the expansion of outpatient treatment, and the proliferation of digital pharmacies. Furthermore, key trends in the forecast period include the increasing adoption in hypertension management, the rise of generic angiotensin receptor blockers, a growing preference for combination cardiovascular therapy, the expansion of online pharmacy distribution, and an enhanced focus on renal and cardiovascular protection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp

What Major Growth Factors Are Impacting The Sartans Market?

The increasing occurrence of hypertension is anticipated to fuel the expansion of the sartans market in the future. This condition is characterized by persistently elevated blood pressure, which increases the risk of heart disease, stroke, and other serious health issues. An escalating rate of hypertension is associated with diets high in salt and processed items, contributing to fluid retention and greater stress on the heart. Sartans manage hypertension by obstructing angiotensin II, a hormone responsible for constricting blood vessels. This action aids in relaxing and widening these vessels, thereby reducing blood pressure and lessening the heart’s effort. As an illustration, in September 2025, according to the World Health Organization, a Switzerland-based international public health agency, an estimated 1.4 billion adults aged 30–79 years worldwide were living with hypertension in 2024, which accounts for approximately 33% of the global population. Consequently, the growing prevalence of hypertension is propelling the growth of the sartans market.

Which Segment Divisions Form The Structure Of The Sartans Market?

The sartans market covered in this report is segmented –

1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

4) By End-User: Hospitals, Other End-Users

Subsegments:

1) By Valsartan: Film-Coated Tablets, Oral Powder Sachets, Triple-Combination Tablets, Ready-To-Use Liquid Formulations

2) By Telmisartan: Soft Gel Capsules, Mouth-Dissolving Strips, Sustained-Release Tablets, Sachet-Packed Granules

3) By Losartan: Chewable Tablets, Pediatric Oral Drops, Effervescent Tablets, Dispersible Tablets

4) By Irbesartan: High-Potency Tablets, Scored Tablets, Hospital Bulk Packs, Blister Strip Packs

5) By Azilsartan: Nanoparticle-Based Tablets, Rapid-Onset Tablets, Unit-Dose Capsules, Microgranule Sachets

6) By Olmesartan: Oral Jelly Formulations, Oral Thin Films, Powder-For-Suspension Packs, Dual-Layer Tablets

What Trends Are Influencing The Sartans Market Outlook?

Major companies operating in the sartans market are prioritizing the development of advanced offerings, such as tablet-form sartans, to improve treatment effectiveness and patient adherence. Tablet-form sartans are oral drugs containing sartan compounds that work by blocking the effects of angiotensin II, which helps relax blood vessels and lower blood pressure. For example, in July 2024, Zydus Lifesciences, an India-based pharmaceutical entity, secured approval from the US Food and Drug Administration (FDA) for Valsartan Tablets USP (40 mg, 80 mg). These tablets are commercially available under the brand name Diovan. They are prescribed for treating hypertension and heart failure, enhancing survival rates after a heart attack in adults, and are also suitable for pediatric patients aged one year and older.

Who Are The Prominent Players Across The Sartans Market?

Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Abbott Laboratories, Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co. Inc.

Access The Complete Sartans Market Report:

https://www.thebusinessresearchcompany.com/report/sartans-global-market-report

What Is The Largest Regional Market In The Sartans Market?

North America was the largest region in the sartans market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Sartans Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp

Browse Through More Reports Similar to the Global Sartans Market 2026, By The Business Research Company

Canned Sardines Market Report 2026

https://www.thebusinessresearchcompany.com/report/canned-sardines-global-market-report

Sarcoma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/sarcoma-drugs-global-market-report

Pineapples Market Report 2026

https://www.thebusinessresearchcompany.com/report/pineapples-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795